SABSW
SAB Biotherapeutics, Inc. Warrant
stockNASDAQWarrant
At CloseOct 2, 2026
0.014USD0.000%(0.00)77,598
Pre-marketOct 1, 2026 9:16:30 AM EDT
0.013USD-7.143%(-0.001)
Loading…
Loading…
130,060
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Previous Close
$0.01
Beta
-0.14
52-Week High
$0.20 2026-08-19
52-Week Low
$0.00 2026-07-27
SMA 50
$0.02
SMA 200
$0.02
Avg. Vol 10D
23,847
Avg. Vol 30D
71,254
Avg. Vol 90D
102,112
Relative Vol
1.09
9.29M
8.62M
92.82%
0.01%
1.00
60%/40%
3.74%
9,919
63,455
477,370
Sep 22, 2026
SABSW Profile
sab biotherapeutics is a clinical-stage biopharmaceutical development company using its novel immunotherapy platform to produce life-saving therapies.
SABSW Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.01 | 2026-09-28 | -0.01% | 0.004 |
| 1M | 0.02 | 2026-09-04 | -40.68% | 10.735 |
| 3M | 0.01 | 2026-07-06 | +33.33% | 5.767 |
| 6M | 0.03 | 2026-04-06 | -44.66% | 0.576 |
| 1Y | 0.04 | 2025-10-06 | -65.75% | -0.141 |
| 2Y | 0.03 | 2024-10-07 | -44.44% | — |
| 5Y | 1.00 | 2021-10-05 | -98.60% | -0.076 |
SABSW Stock Summary
SAB Biotherapeutics, Inc. Warrant (NASDAQ:SABSW) stock price today is $0.01, and today's volume is 77,598. SABSW is up 0.000% today. The 30 day average volume is 71,254. SABSW market cap is $130,060 with 9.29M shares outstanding.